Close

SDC1

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

The protein encoded by this gene is a transmembrane (type I) heparan sulfate proteoglycan and is a member of the syndecan proteoglycan family. The syndecans mediate cell binding, cell signaling, and cytoskeletal organization and syndecan receptors are required for internalization of the HIV1 tat protein. The syndecan1 protein functions as an integral membrane protein and participates in cell proliferation, cell migration and cellmatrix interactions via its receptor for extracellular matrix proteins. Altered syndecan1 expression has been detected in several different tumor types. While several transcript variants may exist for this gene, the fulllength natures of only two have been described to date. These two represent the major variants of this gene and encode the same protein.
  • AbTCR Vector Products

Loading...
  • Target Species:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Fab-Host Animal Vector Type Targeting Cell Type Inquiry & Datasheet
XS-0722-ZP3958 Anti-SDC1 X CD3 BsAb Secreting T Cell Redirecting Vector (SDC1xCD3) Human T Cells   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.